A carregar...
Chemotherapy following radium‐223 dichloride treatment in ALSYMPCA
BACKGROUND: Radium‐223 prolongs overall survival in patients with castration‐resistant prostate cancer (CRPC) and symptomatic bone metastases, regardless of prior docetaxel. Whether or not chemotherapy can be safely administered following radium‐223 treatment is of clinical importance. An explorator...
Na minha lista:
| Publicado no: | Prostate |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5071661/ https://ncbi.nlm.nih.gov/pubmed/27004570 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pros.23180 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|